The two HMOs that received approval in China include GlyCare 2’-fucosyllactose (2’-FL), the most prevalent HMO in human breast milk, and GlyCare lacto-N-neotetraose (LNnT) dsm-firmenich, the leading innovator in health, nutrition and beauty, announced that two of its human milk oligosaccharide (HMO) ingredients have been approved as fortifiers for infant[Read More…]